While no oncogenic role has been reported for the Y191H substitution, this study highlights the significance of investigating ERα structure to extend our understanding of the mechanisms implicated in its activity and their potential roles in breast cancer development and endocrine resistance. Here, ESR1 is linked to breast carcinoma.